TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE was reported 32022 times

These side effects are most commonly reported by patients taking TRIAMCINOLONE ACETONIDE:

# Side effect Count
0 DRUG INEFFECTIVE 5382
1 OFF LABEL USE 3025
2 PRURITUS 2833
3 RASH 2667
4 PAIN 2283
5 FATIGUE 2216
6 NAUSEA 2131
7 HEADACHE 1983
8 DIARRHOEA 1824
9 CONDITION AGGRAVATED 1822
10 PRODUCT USE IN UNAPPROVED INDICATION 1808
11 VOMITING 1782
12 DIZZINESS 1678
13 ARTHRALGIA 1634
14 MALAISE 1464
15 URTICARIA 1436
16 PYREXIA 1428
17 INFUSION RELATED REACTION 1423
18 DYSPNOEA 1417
19 SYNOVITIS 1411
20 WEIGHT INCREASED 1410
21 RHEUMATOID ARTHRITIS 1391
22 HYPOAESTHESIA 1361
23 HYPERTENSION 1350
24 JOINT SWELLING 1343
25 WOUND 1301
26 SWELLING 1285
27 HYPERSENSITIVITY 1275
28 SYSTEMIC LUPUS ERYTHEMATOSUS 1270
29 PERIPHERAL SWELLING 1233
30 NASOPHARYNGITIS 1213
31 GLOSSODYNIA 1197
32 INSOMNIA 1186
33 PSORIATIC ARTHROPATHY 1181
34 TYPE 2 DIABETES MELLITUS 1169
35 WHEEZING 1167
36 PAIN IN EXTREMITY 1161
37 ALOPECIA 1157
38 IMPAIRED HEALING 1147
39 MOBILITY DECREASED 1140
40 HAND DEFORMITY 1136
41 DRY SKIN 1135
42 ABDOMINAL DISCOMFORT 1133
43 INFECTION 1119
44 DRUG INTOLERANCE 1106
45 FOLLICULITIS 1103
46 STOMATITIS 1094
47 IRRITABLE BOWEL SYNDROME 1087
48 PEMPHIGUS 1065
49 DRUG HYPERSENSITIVITY 1064
50 FIBROMYALGIA 1062
51 PRODUCT USE ISSUE 1057
52 GENERAL PHYSICAL HEALTH DETERIORATION 1051
53 ASTHENIA 1045
54 SLEEP DISORDER 1027
55 HEPATIC ENZYME INCREASED 1023
56 PNEUMONIA 1021
57 JOINT RANGE OF MOTION DECREASED 1008
58 PSORIASIS 1008
59 ARTHROPATHY 1005
60 CONFUSIONAL STATE 998
61 INTENTIONAL PRODUCT USE ISSUE 984
62 INFLAMMATION 983
63 WEIGHT DECREASED 980
64 HELICOBACTER INFECTION 972
65 PERICARDITIS 967
66 INJURY 963
67 DUODENAL ULCER PERFORATION 957
68 ABDOMINAL PAIN UPPER 955
69 DRY MOUTH 952
70 BLISTER 936
71 DERMATITIS ATOPIC 904
72 DEPRESSION 903
73 PARAESTHESIA 900
74 SINUSITIS 900
75 OBESITY 876
76 MEMORY IMPAIRMENT 864
77 MUSCLE SPASMS 862
78 DECREASED APPETITE 855
79 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 850
80 OSTEOARTHRITIS 848
81 C-REACTIVE PROTEIN INCREASED 843
82 ILL-DEFINED DISORDER 841
83 SKIN EXFOLIATION 834
84 MATERNAL EXPOSURE DURING PREGNANCY 818
85 TREATMENT FAILURE 813
86 DYSPEPSIA 811
87 MUSCLE INJURY 810
88 LIP DRY 809
89 WOUND INFECTION 809
90 LIVER INJURY 808
91 LOWER RESPIRATORY TRACT INFECTION 803
92 RHEUMATIC FEVER 799
93 MACULAR DEGENERATION 798
94 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 796
95 BLOOD CHOLESTEROL INCREASED 791
96 ERYTHEMA 789
97 THERAPEUTIC PRODUCT EFFECT DECREASED 783
98 FACET JOINT SYNDROME 782
99 PRODUCT DOSE OMISSION ISSUE 759
100 ABDOMINAL PAIN 757
101 MUSCULOSKELETAL STIFFNESS 753
102 CONTRAINDICATED PRODUCT ADMINISTERED 752
103 MUSCULOSKELETAL PAIN 751
104 ANXIETY 748
105 INJECTION SITE PAIN 739
106 NIGHT SWEATS 732
107 LUNG DISORDER 727
108 RHEUMATOID FACTOR POSITIVE 727
109 BURSITIS 708
110 GAIT INABILITY 708
111 MIGRAINE 703
112 MUSCULAR WEAKNESS 697
113 DISCOMFORT 685
114 GASTROOESOPHAGEAL REFLUX DISEASE 680
115 BREAST CANCER STAGE III 676
116 FALL 674
117 ECZEMA 673
118 CHEST PAIN 671
119 VISUAL IMPAIRMENT 664
120 OEDEMA 663
121 GASTROINTESTINAL DISORDER 659
122 CONTUSION 653
123 THERAPY NON-RESPONDER 635
124 ROAD TRAFFIC ACCIDENT 630
125 HYPERCHOLESTEROLAEMIA 629
126 COUGH 628
127 C-REACTIVE PROTEIN ABNORMAL 627
128 DEATH 598
129 ARTHRITIS 588
130 PERIPHERAL VENOUS DISEASE 572
131 PRODUCT QUALITY ISSUE 570
132 OEDEMA PERIPHERAL 562
133 SWOLLEN JOINT COUNT INCREASED 557
134 ASTHMA 555
135 SCIATICA 551
136 GAIT DISTURBANCE 548
137 PULMONARY FIBROSIS 547
138 TASTE DISORDER 546
139 THERAPEUTIC RESPONSE DECREASED 533
140 PRESCRIBED UNDERDOSE 525
141 CONSTIPATION 521
142 EXPOSURE DURING PREGNANCY 521
143 LIVER DISORDER 502
144 BLEPHAROSPASM 497
145 LOWER LIMB FRACTURE 484
146 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 470
147 EPILEPSY 468
148 LIVE BIRTH 466
149 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 463
150 NAIL DISORDER 460
151 UNDERDOSE 456
152 PRESCRIBED OVERDOSE 452
153 RED BLOOD CELL SEDIMENTATION RATE INCREASED 451
154 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 446
155 ADRENAL INSUFFICIENCY 443
156 GRIP STRENGTH DECREASED 438
157 BACK PAIN 433
158 ADVERSE EVENT 415
159 FEELING ABNORMAL 410
160 HYPOTENSION 408
161 DRUG-INDUCED LIVER INJURY 389
162 OSTEOPOROSIS 386
163 DEEP VEIN THROMBOSIS POSTOPERATIVE 383
164 LIVER FUNCTION TEST INCREASED 382
165 NECK PAIN 382
166 NO ADVERSE EVENT 382
167 EPISTAXIS 380
168 SKIN FISSURES 380
169 BLOOD PRESSURE INCREASED 378
170 VISION BLURRED 373
171 ANAEMIA 371
172 INJECTION SITE REACTION 361
173 UPPER RESPIRATORY TRACT INFECTION 361
174 JOINT STIFFNESS 358
175 AUTOIMMUNE DISORDER 353
176 AMNESIA 352
177 COVID-19 342
178 NASAL CONGESTION 337
179 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 333
180 ABDOMINAL DISTENSION 331
181 DELIRIUM 324
182 FREQUENT BOWEL MOVEMENTS 321
183 DISLOCATION OF VERTEBRA 320
184 DRUG INTERACTION 320
185 EYE PAIN 320
186 URINARY TRACT INFECTION 320
187 HOSPITALISATION 317
188 LOSS OF CONSCIOUSNESS 316
189 FOOT DEFORMITY 313
190 HYPERHIDROSIS 307
191 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 304
192 ONYCHOMADESIS 304
193 JOINT DISLOCATION 298
194 RETINITIS 298
195 EXOSTOSIS 296
196 LARYNGITIS 294
197 BACK INJURY 293
198 POLYARTHRITIS 290
199 RECTAL HAEMORRHAGE 290
200 DRY EYE 288
201 SEPTIC SHOCK 288
202 ADVERSE DRUG REACTION 287
203 ILLNESS 287
204 RASH PRURITIC 285
205 RHINORRHOEA 285
206 CROHN^S DISEASE 284
207 BRONCHITIS 282
208 LUPUS VULGARIS 280
209 LUPUS-LIKE SYNDROME 277
210 OROPHARYNGEAL PAIN 277
211 OCULAR HYPERAEMIA 273
212 HIP ARTHROPLASTY 265
213 TACHYCARDIA 265
214 COLITIS ULCERATIVE 264
215 EAR INFECTION 264
216 INCORRECT DOSE ADMINISTERED 262
217 ONYCHOMYCOSIS 260
218 HEPATIC CIRRHOSIS 259
219 HYPOKALAEMIA 251
220 MEDICATION ERROR 249
221 KNEE ARTHROPLASTY 248
222 EYE PRURITUS 243
223 BONE EROSION 242
224 CHRONIC SINUSITIS 242
225 SKIN HAEMORRHAGE 241
226 C-REACTIVE PROTEIN 238
227 PROCEDURAL PAIN 235
228 IMMUNODEFICIENCY 234
229 CUSHING^S SYNDROME 229
230 MYALGIA 227
231 PARAESTHESIA ORAL 227
232 INJECTION SITE SWELLING 226
233 SOMNOLENCE 225
234 CATARACT 224
235 FEELING HOT 224
236 PLEURAL EFFUSION 223
237 X-RAY ABNORMAL 219
238 HEPATITIS 217
239 ACCIDENTAL EXPOSURE TO PRODUCT 213
240 FINGER DEFORMITY 212
241 FLUID RETENTION 212
242 EYE IRRITATION 210
243 GASTROENTERITIS VIRAL 210
244 SKIN DISCOLOURATION 210
245 THERAPEUTIC RESPONSE SHORTENED 209
246 HAEMATOCHEZIA 205
247 JOINT DESTRUCTION 205
248 OVERDOSE 205
249 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 203
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 199
251 COLITIS 198
252 NEPHROLITHIASIS 198
253 ORAL CANDIDIASIS 198
254 PRODUCT STORAGE ERROR 198
255 BLOOD GLUCOSE INCREASED 197
256 COELIAC DISEASE 197
257 INFLUENZA 195
258 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 192
259 PRODUCT LABEL CONFUSION 189
260 THROMBOCYTOPENIA 182
261 HYPOCALCAEMIA 181
262 ADVERSE REACTION 180
263 WALKING AID USER 179
264 INJECTION SITE ERYTHEMA 178
265 INTRAOCULAR PRESSURE INCREASED 178
266 VISUAL ACUITY REDUCED 178
267 HEART RATE INCREASED 177
268 BONE DENSITY DECREASED 176
269 DISABILITY 176
270 FLUSHING 176
271 PALPITATIONS 176
272 ENDOPHTHALMITIS 175
273 VAGINAL DISCHARGE 174
274 NEUROPATHY PERIPHERAL 172
275 RASH ERYTHEMATOUS 172
276 BURNING SENSATION 170
277 LACRIMATION INCREASED 169
278 INTENTIONAL PRODUCT MISUSE 167
279 RASH MACULAR 167
280 NIGHTMARE 166
281 INJECTION SITE ATROPHY 165
282 RADICULOPATHY 165
283 TREMOR 164
284 FEMALE GENITAL TRACT FISTULA 163
285 SERONEGATIVE ARTHRITIS 159
286 BREAST CANCER STAGE II 157
287 CHEST DISCOMFORT 157
288 EAR PAIN 157
289 PROCTITIS 156
290 SWELLING FACE 156
291 LIMB DISCOMFORT 155
292 VAGINAL FLATULENCE 155
293 CHILLS 153
294 DEHYDRATION 153
295 DRUG TOLERANCE 151
296 SEDATION 151
297 PREGNANCY 148
298 SKIN BURNING SENSATION 146
299 WHEELCHAIR USER 146
300 EXPIRED PRODUCT ADMINISTERED 145
301 NODULE 145
302 JUVENILE IDIOPATHIC ARTHRITIS 143
303 STAPHYLOCOCCAL INFECTION 143
304 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 142
305 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 141
306 BALANCE DISORDER 139
307 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 139
308 CHRONIC KIDNEY DISEASE 138
309 SCRATCH 138
310 BODY HEIGHT BELOW NORMAL 137
311 RESPIRATORY DISORDER 137
312 SKIN DISORDER 137
313 SEPSIS 135
314 DERMATITIS 134
315 EXTRA DOSE ADMINISTERED 134
316 RENAL FAILURE 134
317 DISEASE PROGRESSION 133
318 MATERNAL EXPOSURE TIMING UNSPECIFIED 131
319 STRESS 131
320 SKIN ATROPHY 130
321 ANAPHYLACTIC REACTION 129
322 BLINDNESS 129
323 HAEMOGLOBIN DECREASED 129
324 ANTIBODY TEST POSITIVE 128
325 PRODUCTIVE COUGH 128
326 ACUTE KIDNEY INJURY 127
327 WHITE BLOOD CELL COUNT DECREASED 127
328 DRUG EFFECT INCOMPLETE 126
329 CONJUNCTIVITIS 125
330 NON-INFECTIOUS ENDOPHTHALMITIS 125
331 THERAPY PARTIAL RESPONDER 125
332 THROAT IRRITATION 125
333 DYSPHONIA 124
334 DERMATITIS CONTACT 122
335 HOT FLUSH 121
336 WHITE BLOOD CELL COUNT INCREASED 121
337 DYSPNOEA EXERTIONAL 120
338 PLATELET COUNT DECREASED 120
339 EYE SWELLING 119
340 SNEEZING 119
341 SKIN IRRITATION 118
342 UNEVALUABLE EVENT 117
343 CELLULITIS 116
344 HERPES ZOSTER 116
345 INCORRECT PRODUCT ADMINISTRATION DURATION 116
346 INJECTION SITE BRUISING 115
347 INJECTION SITE PRURITUS 115
348 INFUSION SITE PAIN 114
349 CEREBROVASCULAR ACCIDENT 113
350 OCULAR HYPERTENSION 113
351 POOR QUALITY PRODUCT ADMINISTERED 113
352 SKIN ULCER 112
353 SYNCOPE 112
354 INFLUENZA LIKE ILLNESS 110
355 ATRIAL FIBRILLATION 109
356 BACK DISORDER 109
357 HYPOCHOLESTEROLAEMIA 109
358 PANCREATITIS 109
359 THERAPY INTERRUPTED 107
360 NORMAL NEWBORN 106
361 DYSPHAGIA 105
362 GLAUCOMA 105
363 DYSGEUSIA 104
364 SKIN SWELLING 104
365 SEASONAL ALLERGY 102
366 SKIN LESION 102
367 EXPOSURE VIA SKIN CONTACT 101
368 HAEMORRHAGE 101
369 NASAL DISCOMFORT 101
370 FUNGAL INFECTION 100
371 LIVER FUNCTION TEST ABNORMAL 99
372 PRODUCT DELIVERY MECHANISM ISSUE 99
373 SURGERY 99
374 RESPIRATORY TRACT INFECTION 98
375 PORPHYRIA ACUTE 95
376 RETINAL ARTERY OCCLUSION 95
377 THROMBOSIS 95
378 EYE DISORDER 94
379 OXYGEN SATURATION DECREASED 93
380 BONE PAIN 92
381 PRODUCT DOSE OMISSION IN ERROR 92
382 PULMONARY EMBOLISM 92
383 SEIZURE 92
384 EYE INFLAMMATION 91
385 THERAPEUTIC RESPONSE UNEXPECTED 91
386 APPLICATION SITE PAIN 90
387 DRUG TOLERANCE DECREASED 90
388 INFUSION SITE REACTION 90
389 SKIN WEEPING 90
390 VERTIGO 90
391 ACNE 89
392 LABORATORY TEST ABNORMAL 89
393 INJECTION SITE RASH 88
394 JOINT INJURY 88
395 EMOTIONAL DISTRESS 86
396 SUICIDAL IDEATION 86
397 MYOSITIS 85
398 ORAL HERPES 85
399 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 84
400 FLATULENCE 84
401 SPONDYLITIS 84
402 DIABETES MELLITUS 83
403 DISEASE RECURRENCE 83
404 INCORRECT PRODUCT STORAGE 82
405 RASH VESICULAR 82
406 DRUG DOSE OMISSION 81
407 INJECTION SITE DISCOLOURATION 81
408 INTENTIONAL DOSE OMISSION 81
409 BLOOD PRESSURE DECREASED 80
410 TINNITUS 80
411 INFUSION SITE ERYTHEMA 79
412 PUSTULAR PSORIASIS 79
413 TREATMENT NONCOMPLIANCE 79
414 DEEP VEIN THROMBOSIS 78
415 NASAL DRYNESS 78
416 PAIN OF SKIN 78
417 VIRAL INFECTION 78
418 INJECTION SITE HAEMORRHAGE 76
419 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 76
420 IMPAIRED QUALITY OF LIFE 75
421 WEIGHT FLUCTUATION 75
422 HYPOACUSIS 74
423 INJECTION SITE MASS 74
424 ULCER HAEMORRHAGE 74
425 CARDIAC DISORDER 73
426 MUSCLE SPASTICITY 73
427 POLLAKIURIA 72
428 AGEUSIA 71
429 CENTRAL SEROUS CHORIORETINOPATHY 71
430 LEUKOPENIA 71
431 LIMB INJURY 71
432 PRODUCT DOSE OMISSION 71
433 SCAR 71
434 DRUG EFFECT LESS THAN EXPECTED 70
435 HEPATIC ENZYME 70
436 FOETAL EXPOSURE DURING PREGNANCY 69
437 IRRITABILITY 69
438 QUALITY OF LIFE DECREASED 69
439 RETINAL DETACHMENT 69
440 SINUS DISORDER 69
441 JOINT EFFUSION 68
442 SPINAL FUSION SURGERY 68
443 AGITATION 67
444 ANOSMIA 67
445 EYE DISCHARGE 67
446 ORAL PAIN 67
447 DRUG EFFECT DECREASED 66
448 SWOLLEN JOINT COUNT 66
449 MYOCARDIAL INFARCTION 65
450 NEUTROPENIA 65
451 CARDIAC FAILURE CONGESTIVE 64
452 DEVICE ISSUE 64
453 DRUG SPECIFIC ANTIBODY 64
454 TENDERNESS 64
455 PAIN IN JAW 63
456 SCAB 63
457 HALLUCINATION 62
458 HYPOXIA 62
459 NERVOUSNESS 62
460 PHOTOPHOBIA 62
461 UVEITIS 62
462 CYTOMEGALOVIRUS CHORIORETINITIS 61
463 EYE INFECTION 61
464 GENERAL SYMPTOM 61
465 RESPIRATORY FAILURE 61
466 CONGENITAL ANOMALY 60
467 DYSURIA 60
468 LYMPHADENOPATHY 60
469 RETINAL HAEMORRHAGE 60
470 SKIN HYPOPIGMENTATION 60
471 BLOOD POTASSIUM DECREASED 59
472 BONE DENSITY INCREASED 59
473 DEPRESSED MOOD 59
474 FOOT OPERATION 58
475 NEOPLASM MALIGNANT 58
476 OSTEONECROSIS 58
477 PAPULE 58
478 SKIN PLAQUE 58
479 INFUSION SITE SWELLING 57
480 RENAL IMPAIRMENT 57
481 INJECTION SITE URTICARIA 56
482 MUSCLE ATROPHY 56
483 OCULAR DISCOMFORT 56
484 SLEEP APNOEA SYNDROME 56
485 BODY TEMPERATURE INCREASED 55
486 INCORRECT ROUTE OF DRUG ADMINISTRATION 55
487 LETHARGY 55
488 LOCALISED INFECTION 55
489 MACULAR OEDEMA 55
490 UPPER-AIRWAY COUGH SYNDROME 54
491 SINUS CONGESTION 53
492 DIPLOPIA 52
493 THROAT TIGHTNESS 52
494 CANDIDA INFECTION 51
495 HEAD DISCOMFORT 51
496 LIP SWELLING 51
497 ATROPHY 50
498 CHOLELITHIASIS 50
499 HAEMORRHOIDS 50
500 HYPONATRAEMIA 50
501 PANIC ATTACK 50
502 URINARY INCONTINENCE 50
503 ANKLE ARTHROPLASTY 49
504 EAR DISCOMFORT 49
505 GASTRIC DISORDER 49
506 MALIGNANT NEOPLASM PROGRESSION 49
507 ALANINE AMINOTRANSFERASE INCREASED 48
508 APPLICATION SITE ERYTHEMA 47
509 CHORIORETINOPATHY 47
510 CUSHINGOID 47
511 CYSTITIS 47
512 DERMATITIS ALLERGIC 47
513 DEVICE MALFUNCTION 47
514 EYE INFECTION TOXOPLASMAL 47
515 GASTROINTESTINAL HAEMORRHAGE 47
516 HYPERSOMNIA 47
517 MOOD SWINGS 47
518 ADRENAL SUPPRESSION 46
519 ANHEDONIA 46
520 BLOOD CREATININE INCREASED 46
521 INTERVERTEBRAL DISC PROTRUSION 46
522 NECROTISING RETINITIS 46
523 PHOTOSENSITIVITY REACTION 46
524 PRODUCT USE COMPLAINT 46
525 ASPARTATE AMINOTRANSFERASE INCREASED 45
526 CARDIAC FAILURE 45
527 HAEMOPTYSIS 45
528 HEAD INJURY 45
529 INSURANCE ISSUE 45
530 PERIORBITAL SWELLING 45
531 RED BLOOD CELL COUNT DECREASED 45
532 SEBORRHOEIC KERATOSIS 45
533 DISTURBANCE IN ATTENTION 44
534 HEART RATE DECREASED 44
535 REBOUND EFFECT 44
536 SKIN MASS 44
537 TOOTHACHE 44
538 VITREOUS FLOATERS 44
539 DRUG ADMINISTRATION ERROR 43
540 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 43
541 RASH PAPULAR 43
542 RIB FRACTURE 43
543 ACCIDENTAL OVERDOSE 42
544 MUSCULOSKELETAL DISCOMFORT 42
545 PRODUCT ADMINISTRATION INTERRUPTED 42
546 RESPIRATORY TRACT CONGESTION 42
547 SPEECH DISORDER 42
548 ABSCESS 41
549 CRYING 41
550 FEELING JITTERY 41
551 NEURODERMATITIS 41
552 SKIN INFECTION 41
553 SKIN LACERATION 41
554 BASAL CELL CARCINOMA 40
555 BLOOD PRESSURE FLUCTUATION 40
556 BRAIN FOG 40
557 DRUG DEPENDENCE 40
558 DRY THROAT 40
559 FEBRILE NEUTROPENIA 40
560 NEURALGIA 40
561 PULMONARY OEDEMA 40
562 RASH GENERALISED 40
563 VITAMIN D DEFICIENCY 40
564 APPLICATION SITE PRURITUS 39
565 DYSSTASIA 39
566 EYE INJURY 39
567 HEPATIC STEATOSIS 39
568 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 39
569 LIGAMENT SPRAIN 39
570 MENTAL DISORDER 39
571 PHARYNGITIS STREPTOCOCCAL 39
572 PRODUCT PRESCRIBING ISSUE 39
573 PULMONARY HYPERTENSION 39
574 SKIN REACTION 39
575 VITAMIN D DECREASED 39
576 CHROMATURIA 38
577 ECONOMIC PROBLEM 38
578 GOUT 38
579 MULTIPLE ALLERGIES 38
580 PIGMENTATION DISORDER 38
581 ROSACEA 38
582 ROTATOR CUFF SYNDROME 38
583 SHORT STATURE 38
584 TOOTH DISORDER 38
585 BACTERIAL INFECTION 37
586 BLOOD GLUCOSE DECREASED 37
587 ERYTHEMA OF EYELID 37
588 HAEMATURIA 37
589 HIDRADENITIS 37
590 MULTIPLE SCLEROSIS RELAPSE 37
591 POST PROCEDURAL COMPLICATION 37
592 PRODUCT PHYSICAL CONSISTENCY ISSUE 37
593 RENAL DISORDER 37
594 BLOOD PRESSURE SYSTOLIC INCREASED 36
595 END STAGE RENAL DISEASE 36
596 FOOT FRACTURE 36
597 HYPERLIPIDAEMIA 36
598 INCREASED TENDENCY TO BRUISE 36
599 INJECTION SITE IRRITATION 36
600 KIDNEY INFECTION 36
601 MUSCLE TWITCHING 36
602 OSTEOPENIA 36
603 PLATELET COUNT INCREASED 36
604 CARPAL TUNNEL SYNDROME 35
605 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35
606 FEELING COLD 35
607 GASTRITIS 35
608 HYPERKERATOSIS 35
609 HYPOTHYROIDISM 35
610 MUSCLE STRAIN 35
611 REBOUND ATOPIC DERMATITIS 35
612 SECRETION DISCHARGE 35
613 SUSPECTED OFF LABEL USE 35
614 SWOLLEN TONGUE 35
615 ULCER 35
616 BONE DISORDER 34
617 CYSTOID MACULAR OEDEMA 34
618 DIVERTICULITIS 34
619 HYPERGLYCAEMIA 34
620 INJECTION SITE WARMTH 34
621 LEUKOCYTOSIS 34
622 PARANASAL SINUS DISCOMFORT 34
623 PRESYNCOPE 34
624 RESPIRATORY DISTRESS 34
625 RETCHING 34
626 RHINALGIA 34
627 SENSITIVE SKIN 34
628 TOOTH INFECTION 34
629 URINARY RETENTION 34
630 COGNITIVE DISORDER 33
631 DEVICE DISLOCATION 33
632 HYPOPHAGIA 33
633 INITIAL INSOMNIA 33
634 PLASMA CELL MYELOMA 33
635 RESTLESS LEGS SYNDROME 33
636 SKIN CANCER 33
637 TRANSIENT ISCHAEMIC ATTACK 33
638 ANGIOEDEMA 32
639 BRADYCARDIA 32
640 DEAFNESS 32
641 MENSTRUATION IRREGULAR 32
642 NEEDLE ISSUE 32
643 PAROSMIA 32
644 PRODUCT PRESCRIBING ERROR 32
645 SECONDARY ADRENOCORTICAL INSUFFICIENCY 32
646 SKIN HYPERPIGMENTATION 32
647 SPINAL OSTEOARTHRITIS 32
648 VAGINAL HAEMORRHAGE 32
649 BREAST CANCER STAGE I 31
650 PHARYNGEAL OEDEMA 31
651 PNEUMONIA VIRAL 31
652 PRURITUS GENERALISED 31
653 PSEUDOMENINGOCELE 31
654 SWELLING OF EYELID 31
655 TENDON RUPTURE 31
656 TENDONITIS 31
657 TOPICAL STEROID WITHDRAWAL REACTION 31
658 WITHDRAWAL SYNDROME 31
659 APPLICATION SITE IRRITATION 30
660 BLOOD SODIUM DECREASED 30
661 BREAST CANCER 30
662 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30
663 CYST 30
664 DYSKINESIA 30
665 ESSENTIAL HYPERTENSION 30
666 FLANK PAIN 30
667 FULL BLOOD COUNT DECREASED 30
668 INFUSION SITE DISCHARGE 30
669 PANCYTOPENIA 30
670 PNEUMONIA ASPIRATION 30
671 POOR QUALITY SLEEP 30
672 SKIN ABRASION 30
673 SKIN WARM 30
674 TOOTH FRACTURE 30
675 BLINDNESS UNILATERAL 29
676 BLOOD IRON DECREASED 29
677 BLOOD PRESSURE ABNORMAL 29
678 ERYTHEMA MULTIFORME 29
679 EYELID PAIN 29
680 FURUNCLE 29
681 INFUSION SITE HAEMORRHAGE 29
682 INTESTINAL OBSTRUCTION 29
683 MASS 29
684 MENORRHAGIA 29
685 NERVE COMPRESSION 29
686 ORAL DISCOMFORT 29
687 PRODUCT USED FOR UNKNOWN INDICATION 29
688 ACUTE RESPIRATORY FAILURE 28
689 ASPIRATION 28
690 EYE ABSCESS 28
691 GLYCOSYLATED HAEMOGLOBIN INCREASED 28
692 HAIR GROWTH ABNORMAL 28
693 HIP FRACTURE 28
694 HYPOPYON 28
695 MIDDLE INSOMNIA 28
696 MOVEMENT DISORDER 28
697 NECROTISING SCLERITIS 28
698 PRODUCT AVAILABILITY ISSUE 28
699 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28
700 SCLERITIS 28
701 ANAPHYLACTIC SHOCK 27
702 BLEPHARITIS 27
703 BLOOD ALKALINE PHOSPHATASE INCREASED 27
704 CONJUNCTIVAL HAEMORRHAGE 27
705 EATING DISORDER 27
706 EYELID MARGIN CRUSTING 27
707 FOREIGN BODY SENSATION IN EYES 27
708 HORDEOLUM 27
709 INFUSION SITE PRURITUS 27
710 MELANOCYTIC NAEVUS 27
711 MULTIPLE SCLEROSIS 27
712 MUSCULOSKELETAL CHEST PAIN 27
713 OSTEOMYELITIS 27
714 PRODUCT ADMINISTRATION ERROR 27
715 PRODUCT DISTRIBUTION ISSUE 27
716 PRODUCT ODOUR ABNORMAL 27
717 PRODUCT PACKAGING ISSUE 27
718 PSEUDOENDOPHTHALMITIS 27
719 RHEGMATOGENOUS RETINAL DETACHMENT 27
720 RHINITIS ALLERGIC 27
721 SINUS HEADACHE 27
722 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 27
723 THIRST 27
724 TYPE I HYPERSENSITIVITY 27
725 VITREOUS OPACITIES 27
726 ANGER 26
727 APHTHOUS ULCER 26
728 ARRHYTHMIA 26
729 ARTHRITIS INFECTIVE 26
730 CLOSTRIDIUM DIFFICILE INFECTION 26
731 CORONARY ARTERY DISEASE 26
732 DISORIENTATION 26
733 FAECES SOFT 26
734 HYPOAESTHESIA ORAL 26
735 IMMUNE SYSTEM DISORDER 26
736 INJECTION SITE DISCOMFORT 26
737 IRON DEFICIENCY ANAEMIA 26
738 MASTITIS BACTERIAL 26
739 OVERLAP SYNDROME 26
740 PERICARDIAL EFFUSION 26
741 PHARYNGITIS 26
742 PRE-EXISTING CONDITION IMPROVED 26
743 PRODUCT PHYSICAL ISSUE 26
744 THINKING ABNORMAL 26
745 VULVOVAGINAL PRURITUS 26
746 ABDOMINAL PAIN LOWER 25
747 ASPERGILLUS INFECTION 25
748 CUSHING'S SYNDROME 25
749 DERMATITIS ACNEIFORM 25
750 DEVICE INFUSION ISSUE 25
751 DIZZINESS POSTURAL 25
752 DRUG WITHDRAWAL SYNDROME 25
753 DYSARTHRIA 25
754 ECCHYMOSIS 25
755 FACIAL PAIN 25
756 INFUSION SITE RASH 25
757 INTERSTITIAL LUNG DISEASE 25
758 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25
759 NERVOUS SYSTEM DISORDER 25
760 NOCTURIA 25
761 OPTIC NEURITIS 25
762 PRODUCT CONTAMINATION 25
763 PRODUCT PREPARATION ERROR 25
764 PULMONARY ARTERIAL HYPERTENSION 25
765 STEROID WITHDRAWAL SYNDROME 25
766 TEMPERATURE INTOLERANCE 25
767 VASCULAR DEVICE INFECTION 25
768 VISUAL FIELD DEFECT 25
769 VITREOUS HAEMORRHAGE 25
770 ARTHROPOD BITE 24
771 CHORIORETINAL DISORDER 24
772 FAECES DISCOLOURED 24
773 GRIP STRENGTH 24
774 IMPAIRED WORK ABILITY 24
775 INCREASED APPETITE 24
776 INTERVERTEBRAL DISC DEGENERATION 24
777 ORAL DISORDER 24
778 PARKINSON^S DISEASE 24
779 PHARYNGEAL SWELLING 24
780 PRODUCT DISPENSING ERROR 24
781 PSEUDOMONAS INFECTION 24
782 RASH MACULO-PAPULAR 24
783 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24
784 RESTLESSNESS 24
785 SKIN EROSION 24
786 SOFT TISSUE DISORDER 24
787 CLOSTRIDIUM DIFFICILE COLITIS 23
788 DEVICE DIFFICULT TO USE 23
789 DEVICE FAILURE 23
790 DRUG ERUPTION 23
791 FLUID OVERLOAD 23
792 GASTRIC ULCER 23
793 HALLUCINATION, VISUAL 23
794 HYPOGLYCAEMIA 23
795 INFECTIVE SCLERITIS 23
796 INTERNATIONAL NORMALISED RATIO INCREASED 23
797 LIQUID PRODUCT PHYSICAL ISSUE 23
798 MADAROSIS 23
799 PANCREATITIS ACUTE 23
800 PRODUCT TASTE ABNORMAL 23
801 REBOUND ECZEMA 23
802 RENAL FAILURE ACUTE 23
803 SEBORRHOEIC DERMATITIS 23
804 SPINAL CORD INFARCTION 23
805 SPINAL OPERATION 23
806 ABNORMAL DREAMS 22
807 AGGRESSION 22
808 ASCITES 22
809 EMOTIONAL DISORDER 22
810 ENCEPHALOPATHY 22
811 FEEDING DISORDER 22
812 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22
813 GLUCOSE TOLERANCE IMPAIRED 22
814 GUTTATE PSORIASIS 22
815 HAEMATOCRIT DECREASED 22
816 HAEMATOMA 22
817 HIATUS HERNIA 22
818 INJECTION SITE INDURATION 22
819 LIPOATROPHY 22
820 LYMPHOCYTE COUNT DECREASED 22
821 MALIGNANT MELANOMA 22
822 MENTAL STATUS CHANGES 22
823 NEOPLASM PROGRESSION 22
824 NEUTROPHIL COUNT DECREASED 22
825 RENAL INJURY 22
826 SENSITIVITY TO WEATHER CHANGE 22
827 THERMAL BURN 22
828 WRIST FRACTURE 22
829 APHONIA 21
830 ATELECTASIS 21
831 BLOOD PRESSURE SYSTOLIC ABNORMAL 21
832 BLOOD URINE PRESENT 21
833 CEREBROSPINAL FLUID LEAKAGE 21
834 COMPLICATION ASSOCIATED WITH DEVICE 21
835 DECREASED ACTIVITY 21
836 DEVICE LEAKAGE 21
837 GROIN PAIN 21
838 HAEMOGLOBIN INCREASED 21
839 HYPERKALAEMIA 21
840 INJECTION SITE INFLAMMATION 21
841 MACULOPATHY 21
842 MOOD ALTERED 21
843 NEPHROGENIC ANAEMIA 21
844 ORBITAL INFECTION 21
845 PRODUCT PREPARATION ISSUE 21
846 PULMONARY CONGESTION 21
847 PULMONARY MASS 21
848 SUICIDE ATTEMPT 21
849 SUNBURN 21
850 THERAPY CESSATION 21
851 TOOTH ABSCESS 21
852 UPPER LIMB FRACTURE 21
853 ANKLE FRACTURE 20
854 BLOOD COUNT ABNORMAL 20
855 DEAFNESS NEUROSENSORY 20
856 DRUG RESISTANCE 20
857 ERUCTATION 20
858 EXPOSURE VIA BREAST MILK 20
859 EYE HAEMORRHAGE 20
860 EYELID PTOSIS 20
861 FEAR 20
862 GENERALISED OEDEMA 20
863 GINGIVAL PAIN 20
864 HEART RATE IRREGULAR 20
865 HYPERTHYROIDISM 20
866 HYPERTRANSAMINASAEMIA 20
867 INJECTION SITE INDENTATION 20
868 INJECTION SITE VESICLES 20
869 INTERNAL HAEMORRHAGE 20
870 LUNG NEOPLASM MALIGNANT 20
871 ONYCHOCLASIS 20
872 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20
873 PETECHIAE 20
874 PNEUMONITIS 20
875 RETINAL PIGMENT EPITHELIAL TEAR 20
876 SQUAMOUS CELL CARCINOMA 20
877 STEVENS-JOHNSON SYNDROME 20
878 TOOTH LOSS 20
879 WOUND SECRETION 20
880 XEROSIS 20
881 ABNORMAL BEHAVIOUR 19
882 ALLERGY TO CHEMICALS 19
883 APHASIA 19
884 APPLICATION SITE DISCOLOURATION 19
885 APPLICATION SITE SWELLING 19
886 ARTHRITIS BACTERIAL 19
887 B-LYMPHOCYTE COUNT DECREASED 19
888 BLINDNESS TRANSIENT 19
889 BLOOD UREA INCREASED 19
890 BOWEL MOVEMENT IRREGULARITY 19
891 BRONCHIECTASIS 19
892 CATARACT SUBCAPSULAR 19
893 CHOKING SENSATION 19
894 DEMENTIA 19
895 DIABETIC RETINAL OEDEMA 19
896 DRUG SPECIFIC ANTIBODY PRESENT 19
897 EAR CONGESTION 19
898 EYELIDS PRURITUS 19
899 FRUSTRATION TOLERANCE DECREASED 19
900 HERNIA 19
901 HOSPICE CARE 19
902 IMPAIRED GASTRIC EMPTYING 19
903 INFUSION SITE EXTRAVASATION 19
904 METAMORPHOPSIA 19
905 NASAL PRURITUS 19
906 OROPHARYNGEAL DISCOMFORT 19
907 PEMPHIGOID 19
908 POOR VENOUS ACCESS 19
909 POSTMENOPAUSAL HAEMORRHAGE 19
910 PRODUCT CONTAINER ISSUE 19
911 RETINAL VASCULITIS 19
912 SKIN HYPERTROPHY 19
913 SLUGGISHNESS 19
914 SOFT TISSUE SWELLING 19
915 SPINAL FRACTURE 19
916 TENDER JOINT COUNT 19
917 THERAPEUTIC PRODUCT CROSS-REACTIVITY 19
918 URINE ODOUR ABNORMAL 19
919 VASCULITIS 19
920 VITRITIS 19
921 ANAL INCONTINENCE 18
922 ANGINA PECTORIS 18
923 ARTERIOSCLEROSIS CORONARY ARTERY 18
924 BLOOD POTASSIUM INCREASED 18
925 BLOOD TRIGLYCERIDES INCREASED 18
926 CARDIAC ARREST 18
927 CHOROIDITIS 18
928 EYELID SKIN DRYNESS 18
929 GALLBLADDER DISORDER 18
930 GINGIVAL BLEEDING 18
931 GLOMERULAR FILTRATION RATE DECREASED 18
932 HAIR COLOUR CHANGES 18
933 HYPERVOLAEMIA 18
934 HYPOKINESIA 18
935 MACULE 18
936 MOUTH ULCERATION 18
937 OPHTHALMIC HERPES SIMPLEX 18
938 PRODUCT SUBSTITUTION ISSUE 18
939 PSYCHOTIC DISORDER 18
940 SINUS PAIN 18
941 SJOGREN^S SYNDROME 18
942 SPINAL DISORDER 18
943 STREPTOCOCCAL INFECTION 18
944 TENOSYNOVITIS 18
945 THERAPEUTIC PRODUCT EFFECT DELAYED 18
946 ACUTE MYOCARDIAL INFARCTION 17
947 BEDRIDDEN 17
948 CALCINOSIS 17
949 CHRONIC GASTRITIS 17
950 CONJUNCTIVAL ULCER 17
951 CONVULSION 17
952 DEATH NEONATAL 17
953 DERMATITIS PSORIASIFORM 17
954 DEVICE BREAKAGE 17
955 DEVICE USE ISSUE 17
956 DIVERTICULUM 17
957 EMBOLISM 17
958 ERECTILE DYSFUNCTION 17
959 FEAR OF INJECTION 17
960 FOOD ALLERGY 17
961 GASTROINTESTINAL INFECTION 17
962 HAIR TEXTURE ABNORMAL 17
963 HEAVY MENSTRUAL BLEEDING 17
964 HEREDITARY ANGIOEDEMA 17
965 HICCUPS 17
966 HYPOMAGNESAEMIA 17
967 INJECTION SITE ABSCESS 17
968 LOW DENSITY LIPOPROTEIN INCREASED 17
969 MENSTRUAL DISORDER 17
970 NECROSIS 17
971 NERVE INJURY 17
972 ORAL MUCOSAL BLISTERING 17
973 PRODUCT PACKAGING QUANTITY ISSUE 17
974 PROSTATE CANCER 17
975 PUPILLARY REFLEX IMPAIRED 17
976 PURPURA 17
977 RETINAL DEGENERATION 17
978 RETINAL ISCHAEMIA 17
979 RHABDOMYOLYSIS 17
980 RHINITIS 17
981 SENSORY LOSS 17
982 SKIN DISCOMFORT 17
983 SKIN PAPILLOMA 17
984 SNORING 17
985 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 17
986 TELANGIECTASIA 17
987 THERAPEUTIC RESPONSE DELAYED 17
988 THYROID DISORDER 17
989 UNRESPONSIVE TO STIMULI 17
990 VERTIGO POSITIONAL 17
991 BLOOD IRON INCREASED 16
992 CARDIOMEGALY 16
993 CATARACT OPERATION 16
994 CEREBRAL HAEMORRHAGE 16
995 CEREBRAL INFARCTION 16
996 CHAPPED LIPS 16
997 CONJUNCTIVAL HYPERAEMIA 16
998 DELUSION 16
999 DERMATOMYOSITIS 16